AxoGen, Inc. (AXGN) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 15 Buy, 3 Hold.
The consensus price target is $38.38 (low: $34.00, high: $41.00), representing an upside of 11.4% from the current price $34.46.
Analysts estimate Earnings Per Share (EPS) of $0.08 and revenue of $0.19B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.23 vs est $0.08 (missed -379.6%). 2025: actual $-0.34 vs est $0.31 (missed -210.1%). Analyst accuracy: 0%.
AXGN Stock — 12-Month Price Forecast
$38.38
▲ +11.38% Upside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for AxoGen, Inc., the average price target is $38.38, with a high forecast of $41.00, and a low forecast of $34.00.
The average price target represents a +11.38% change from the last price of $34.46.
Highest Price Target
$41.00
Average Price Target
$38.38
Lowest Price Target
$34.00
AXGN Analyst Ratings
Buy
Based on 18 analysts giving stock ratings to AxoGen, Inc. in the past 3 months
EPS Estimates — AXGN
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.23
vs Est $0.08
▼ 135.8% off
2025
Actual –$0.34
vs Est $0.31
▼ 190.8% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Revenue Estimates — AXGN
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.187B
vs Est $0.186B
▲ 0.5% off
2025
Actual $0.225B
vs Est $0.224B
▲ 0.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
